Cargando…
The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes
BACKGROUND: Clinical and basic investigations have indicated a significant association between circulating growth differentiation factor 15 (GDF15) and cardiovascular disease; however, the relationship between GDF15 and lower extremity atherosclerotic disease (LEAD) has been less studied. The presen...
Autores principales: | He, Xingxing, Su, Jiaorong, Ma, Xiaojing, Lu, Wei, Zhu, Wei, Wang, Yufei, Bao, Yuqian, Zhou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103065/ https://www.ncbi.nlm.nih.gov/pubmed/32222153 http://dx.doi.org/10.1186/s12933-020-01020-9 |
Ejemplares similares
-
Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017) -
Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
por: Shen, Yun, et al.
Publicado: (2020) -
Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015) -
Suppressing Effect of Free Triiodothyronine on the Negative Association between Body Mass Index and Serum Osteocalcin Levels in Euthyroid Population
por: Nie, Xiaomin, et al.
Publicado: (2021) -
Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2021)